AMSBIO introduces StemFit® Basic04, a next generation feeder-free medium for the maintenance of Induced Pluripotent Stem (iPS) and Embryonic Stem (ES) cells during the reprogramming, expansion and differentiation phases of stem cell culture. With its fully defined and animal-origin free formulation, StemFit® Basic04 is suited to both research studies and translation to cell therapy.
With the new StemFit® Basic04 it is now possible to experience market-leading colony expansion (scalable 100-fold expansion / week) allowing single-cell cloning and consistent high performance with a range of different matrices. The unique formulation offers flexible weekend free cell culture schedules, with lower than standard media volume consumption, plus fewer passages and media changes.
Provided in a single bottle, StemFit® Basic04 offers several additional advantages to simplify stem cell culture workflows, including a matrix coating-free and scraper-free protocol.
For further information on StemFit® Basic04 please visit http://www.amsbio.com/Feeder-Free-Stem-Cell-Culture.aspx or contact AMSBIO now on +44-1235-828200 / +1-617-945-5033 / email@example.com.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.
For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.